Owens & Minor, Inc. (OMI) Stock Analysis
DELISTED 2026
What happened to Owens & Minor, Inc. (OMI) stock?
Owens & Minor, Inc. (OMI) no longer trades on public markets. It was delisted in January 2026. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Owens & Minor, Inc. (OMI) trades at $2.68. Owens & Minor, Inc. is a healthcare solutions company operating globally. Market cap: $207M, Sector: Healthcare.
Last analyzed: May 9, 2026OMI stock analysis for 2026: Analysts have set a consensus price target of $5.44 for Owens & Minor, Inc., suggesting 103.0% upside from the current price of $2.68. Key factors: analyst coverage, company fundamentals.
OMI: 1/2 scored disciplines lean bearish. Dominant signal: Ken Griffin bullish.
How is this calculated? →Owens & Minor, Inc. (OMI) Healthcare & Pipeline Overview
Owens & Minor is a global healthcare solutions company, providing medical supplies and services to healthcare providers and manufacturers. With a focus on infection prevention and supply chain optimization, the company operates through its Global Solutions and Global Products segments, serving a diverse range of healthcare facilities.
What Is the Investment Thesis for OMI?
Owens & Minor presents a mixed investment thesis. The company's established presence in the healthcare distribution market and its focus on infection prevention products provide a stable revenue base. However, the company's negative profit margin of -23.3% raises concerns about profitability and operational efficiency. Potential growth catalysts include expanding its Global Solutions offerings and capitalizing on the increasing demand for infection control products. Investors should closely monitor the company's ability to improve its profit margins and manage its debt levels. The company's beta of 1.36 suggests higher volatility compared to the market.
Based on FMP financials and quantitative analysis
OMI Key Highlights
Owens & Minor operates in two segments: Global Solutions and Global Products, offering a diversified range of healthcare products and services.
- The company's Global Solutions segment provides supplier management, analytics, and inventory management services to healthcare providers.
- The Global Products segment focuses on manufacturing and sourcing medical surgical products for infection prevention.
- Owens & Minor serves a broad customer base, including hospitals, surgery centers, and physician practices.
- The company's gross margin stands at 31.0%, indicating its ability to generate revenue from sales after accounting for the cost of goods sold.
Who Are OMI's Competitors?
OMI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CAH Cardinal Health, Inc. | $231.00 | -1.64% | $54.1B | 90 |
| MCK McKesson Corporation | $853.71 | -1.79% | $100.0B | 90 |
| ACH Accendra Health, Inc. (ACH) is a healthcare solutions company providing products and services to healthcare providers and patients. The company | $1.31 | -0.76% | $100M | — |
| ZRSEF DocMorris AG | $10.24 | +0.00% | $500M | 41 |
| GEG Great Elm Group, Inc. | $2.15 | +0.00% | $67.4M | — |
| ARRJF Arjo AB (publ) | $2.91 | +0.00% | $793M | 43 |
| HX Akso Health Group | $2.24 | -4.27% | $53.4M | 38 |
| IUSDF AS ONE Corporation | $14.00 | +0.00% | $998M | 46 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are OMI's Key Strengths?
Comprehensive product and service portfolio
- Established relationships with healthcare providers
- Focus on infection prevention
- Global presence
What Are OMI's Weaknesses?
Negative profit margin
- High debt levels
- Dependence on a few large customers
- Exposure to regulatory changes
What Could Drive OMI Stock Higher?
Expansion of Global Solutions offerings to drive revenue growth.
- Focus on infection prevention products to capitalize on market demand.
- Strategic partnerships to expand market reach and service capabilities.
What Are the Key Risks for OMI?
Financial-distress signal — its Altman Z-Score of -0.84 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Intense competition in the healthcare distribution market.
- Pricing pressures from healthcare providers and payers.
- Supply chain disruptions due to global events.
- Changes in healthcare regulations impacting the company's operations.
What Are the Growth Opportunities for OMI?
- Expanding Global Solutions Offerings: Owens & Minor can capitalize on the growing demand for supply chain management and analytics services in the healthcare industry. By expanding its Global Solutions offerings, the company can attract new customers and increase revenue from existing clients. The market for healthcare supply chain management is projected to reach $25 billion by 2028, presenting a significant growth opportunity for Owens & Minor.
- Increasing Focus on Infection Prevention: With the rising awareness of healthcare-associated infections, Owens & Minor can further expand its Global Products segment by developing and marketing innovative infection prevention products. The global market for infection control is expected to reach $20 billion by 2027, driven by stringent regulations and growing concerns about patient safety. Owens & Minor can leverage its expertise in this area to capture a larger share of the market.
- Geographic Expansion: Owens & Minor can pursue geographic expansion opportunities, particularly in emerging markets with growing healthcare infrastructure. By establishing a presence in new regions, the company can diversify its revenue streams and reduce its reliance on the U.S. market. The healthcare market in Asia-Pacific is projected to experience significant growth in the coming years, presenting attractive opportunities for Owens & Minor.
- Strategic Acquisitions: Owens & Minor can pursue strategic acquisitions to expand its product portfolio, enhance its service offerings, and gain access to new markets. By acquiring complementary businesses, the company can strengthen its competitive position and accelerate its growth. Potential acquisition targets could include companies specializing in medical devices, healthcare IT solutions, or supply chain logistics.
- Enhancing Digital Capabilities: Investing in digital technologies can help Owens & Minor improve its operational efficiency, enhance its customer service, and gain a competitive edge. By implementing advanced analytics, automation, and e-commerce platforms, the company can streamline its processes, reduce costs, and provide a better experience for its customers. The market for healthcare IT solutions is expected to grow rapidly in the coming years, driven by the increasing adoption of digital technologies in the healthcare industry.
What Are OMI's Competitive Advantages?
- Established relationships with healthcare providers.
- Comprehensive portfolio of products and services.
- Expertise in supply chain management and logistics.
- Focus on infection prevention.
What Does OMI Do?
Founded in 1882 and headquartered in Mechanicsville, Virginia, Owens & Minor, Inc. has evolved into a leading healthcare solutions company operating in the United States and internationally. Originally established as a wholesale drug company, Owens & Minor has expanded its offerings to include a comprehensive portfolio of medical supplies, equipment, and related services. The company operates through two primary segments: Global Solutions and Global Products. The Global Solutions segment provides a range of services to healthcare providers and manufacturers, including supplier management, analytics, inventory management, and clinical supply management. This segment also offers logistics and marketing solutions to its suppliers. The Global Products segment manufactures and sources medical surgical products focused on preventing healthcare-associated infections. These products include sterilization wraps, surgical drapes and gowns, facial protection products, protective apparel, medical exam gloves, and custom procedure kits. Owens & Minor serves a diverse customer base, including multi-facility healthcare networks, independent hospitals, surgery centers, physician practices, and hospital networks, both directly and through third-party distributors. The company's commitment to innovation and customer service has solidified its position as a key player in the healthcare supply chain.
What Products and Services Does OMI Offer?
- Distributes medical and surgical supplies.
- Provides supply chain management services to healthcare providers.
- Manufactures and sources medical products for infection prevention.
- Offers analytics and inventory management solutions.
- Provides logistics and marketing programs to suppliers.
- Serves hospitals, surgery centers, and physician practices.
How Does OMI Make Money?
- Generates revenue from the sale of medical and surgical supplies.
- Earns fees for providing supply chain management and consulting services.
- Profits from the manufacture and distribution of infection prevention products.
What Industry Does OMI Operate In?
Owens & Minor operates within the healthcare distribution industry, which is characterized by increasing demand for efficient supply chain solutions and infection prevention products. The industry is driven by factors such as an aging population, rising healthcare expenditures, and growing awareness of healthcare-associated infections. The competitive landscape includes major players like Cardinal Health and McKesson, as well as smaller regional distributors. Owens & Minor differentiates itself through its comprehensive portfolio of products and services, as well as its focus on supply chain optimization and clinical support.
Who Are OMI's Key Customers?
- Multi-facility networks of healthcare providers
- Independent hospitals
- Surgery centers
- Physician practices
Key Financial Metrics
Return on equity for Owens & Minor, Inc. stands at 264.5%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -44.8%, showing how much profit it generates from its asset base. Its free cash flow yield is -73.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.49 means current liabilities exceed short-term assets, a liquidity point worth watching.
Owens & Minor, Inc. (OMI) Valuation Context
Valued at $207M, OMI is classified as a micro-cap stock.
Company Profile
Owens & Minor, Inc. operates in the Medical - Distribution industry within the Healthcare sector. It is headquartered in Mechanicsville, US. The company is led by CEO Edward A. Pesicka. OMI has traded publicly since 1980.
Financial Health
Owens & Minor, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -0.84 places it in the distress zone, a signal of elevated financial risk.
Forward Outlook
Wall Street analysts project Owens & Minor, Inc. revenue of about $2.62B for fiscal 2026, with EPS near $0.97. The estimate reflects 4 contributing analysts.
OMI Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying indicates confidence in the company's future, which often reflects strong belief in upcoming growth.
- Community sentiment has shifted positively, with discussions highlighting the company's strategic partnerships and expanding market reach.
- Owens & Minor's focus on enhancing supply chain solutions is resonating well with investors, showcasing adaptability in a changing market.
- Recent news about increased demand for healthcare supplies has sparked optimism about revenue potential, aligning with broader industry trends.
Bear Case
- Concerns about potential supply chain disruptions continue to linger, raising questions about operational stability in the near term.
- Some community members express skepticism about the sustainability of recent growth, citing competitive pressures in the healthcare sector.
- Recent earnings reports have shown mixed results, leading to debates about the company's long-term profitability and efficiency.
- Market perception is clouded by broader economic uncertainties, causing some investors to adopt a cautious stance toward Owens & Minor's outlook.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
OMI Latest News
No recent news available for OMI.
Leadership: Edward A. Pesicka
President and Chief Executive Officer
Edward A. Pesicka serves as the President and Chief Executive Officer of Owens & Minor. Prior to joining Owens & Minor, Pesicka held leadership positions at various healthcare companies, including leadership roles at Cardinal Health. His experience spans across supply chain management, distribution, and healthcare services. Pesicka's expertise lies in driving operational efficiencies, improving financial performance, and fostering a culture of innovation.
Track Record: Since assuming the role of CEO, Edward Pesicka has focused on streamlining operations, improving profitability, and strengthening customer relationships. He has overseen the implementation of strategic initiatives aimed at optimizing the company's supply chain and expanding its service offerings. Under his leadership, Owens & Minor has navigated a challenging healthcare landscape while maintaining its commitment to providing high-quality products and services.
Owens & Minor, Inc. Healthcare Stock: Key Questions Answered
What happened to Owens & Minor, Inc. (OMI) stock?
Owens & Minor, Inc. (OMI) no longer trades on public markets. It was delisted in January 2026. The figures below are historical and are not a current quote.
Can I still buy OMI shares?
No. OMI stopped trading on public markets in January 2026, so the shares are not available through a broker. Anything you see quoted for OMI elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before OMI stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Owens & Minor, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does Owens & Minor, Inc. do?
Owens & Minor, Inc. operates as a healthcare solutions company, providing a comprehensive range of medical supplies, equipment, and related services to healthcare providers and manufacturers. The company's two segments, Global Solutions and Global Products, offer supply chain management, analytics, inventory management, and infection prevention products.
What do analysts say about OMI stock?
Analyst coverage of Owens & Minor stock is mixed, reflecting the company's challenges and opportunities. Some analysts highlight the company's established presence in the healthcare distribution market and its focus on infection prevention products as positive factors. However, concerns remain about the company's negative profit margin and high debt levels.
What are the main risks for OMI?
Owens & Minor faces several key risks, including intense competition in the healthcare distribution market, pricing pressures from healthcare providers and payers, and potential supply chain disruptions. The company's negative profit margin and high debt levels also pose significant challenges. Changes in healthcare regulations and reimbursement policies could negatively impact the company's revenue and profitability.
What are the key growth opportunities for OMI in healthcare?
Owens & Minor has several key growth opportunities within the healthcare sector. Expanding its Global Solutions offerings to provide advanced supply chain management and analytics services can drive revenue growth. Capitalizing on the increasing demand for infection prevention products by developing and marketing innovative solutions is another significant opportunity.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data may be subject to change.
- Analyst opinions may vary.